Results 291 to 300 of about 420,842 (369)
Radioimmunoassay and Some Properties of Human Antibodies to Hepatitis B Core Antigen
A. R. Neurath+4 more
openalex +1 more source
Pediatric Autoimmune Pancreatitis: Clinical Findings and Outcomes in Sweden
ABSTRACT Introduction Pediatric autoimmune pancreatitis (AIP) is a rare form of pancreatitis in children with poorly understood pathophysiology. It is a recognized risk factor for chronic pancreatitis in approximately 4% of pediatric cases. This study aims to describe the demographics, clinical characteristics, and outcomes of a large Swedish cohort of
Miroslav Vujasinovic+9 more
wiley +1 more source
Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases. [PDF]
Zhang Z+10 more
europepmc +1 more source
ABSTRACT Background Cholangiocarcinoma presents a global health challenge due to its increasing incidence and poor prognosis, primarily resulting from delayed diagnosis. There is an urgent need for a reliable biomarker to enhance early detection. Materials and Methods Patients with cholangiocarcinoma were enrolled into three cohorts: a discovery set (n
Lichieh Julie Chu+6 more
wiley +1 more source
Regulators and Conductors of Immunity: Natural Immune System in Health and Autoimmunity. [PDF]
Böröcz K+4 more
europepmc +1 more source
Successful treatment with upadacitinib for Sjögren's syndrome complicated by atopic dermatitis
Rheumatology &Autoimmunity, EarlyView.
Haojie Xu+4 more
wiley +1 more source
The regulatory effects and applications of TIGIT/CD155 on the tumor microenvironment in HCC
Background The interaction between TIGIT and CD155 compromises immune cell efficacy in tumor targeting, potentially driving hepatocellular carcinoma (HCC) progression through diverse molecular pathways. What Was Done This study investigates the interplay between CD155 and TIGIT in regulating CD8+ T cell function and elucidates its implications in HCC ...
Wenting Li+10 more
wiley +1 more source
Maternal Immunization: Current Evidence, Progress, and Challenges. [PDF]
Santilli V+10 more
europepmc +1 more source